Nair Sreekumaran, Lewis Leslie Edward, Godinho Myron Anthony, Murthy Shruti, Lakiang Theophilus, Venkatesh Bhumika T
Public Health Evidence South Asia (PHESA), Manipal University, Manipal, India.
Department of Pediatrics, Neonatology Unit, Kasturba Medical College, Manipal University, Manipal, India.
BMJ Open. 2018 Jan 10;8(1):e018790. doi: 10.1136/bmjopen-2017-018790.
India accounts for more neonatal deaths than any other country. There is a lack of consolidated evidence from India regarding the determining factors of pneumonia in neonates. This systematic review is aimed to consolidate and appraise the evidence on risk factors and determinants of pneumonia among neonates in India.
This protocol is part of a project consisting of three reviews (two systematic reviews and one scoping review) and a qualitative study on neonatal pneumonia in India. English language observational studies which report risk factors and determinants of neonatal pneumonia in India will be eligible for inclusion. Electronic searching of nine databases, and hand searching will be done. Two authors will independently conduct screening (title, abstract and full-text stages), extract data and assess risk of bias. A meta-analysis is planned to be performed with random-effects model. A narrative synthesis will be used to summarise the characteristics and findings of the review, if a meta-analysis cannot be performed. If there are more than 10 studies, publication bias will be assessed. Sensitivity and subgroup analysis will performed based on data availability. The quality of our review will be assessed by using 'Assessing the Methodological quality of Systematic Reviews' and 'Grades of Recommendation, Assessment, Development and Evaluation'.
The protocol of the entire project has been approved by the host institution's ethics body (Institutional Ethics Committee, Manipal University, Manipal, India), and the 'Health Ministry Screening Committee' under the Ministry of Health and Family Welfare, Government of India. The study findings will be disseminated among relevant stakeholders using knowledge dissemination workshops, policy briefs, publications, etc.
CRD42016044019.
印度的新生儿死亡人数比其他任何国家都多。印度缺乏关于新生儿肺炎决定因素的综合证据。本系统评价旨在汇总和评估印度新生儿肺炎危险因素和决定因素的证据。
本方案是一个项目的一部分,该项目包括三项评价(两项系统评价和一项范围界定评价)以及一项关于印度新生儿肺炎的定性研究。报道印度新生儿肺炎危险因素和决定因素的英文观察性研究将符合纳入标准。将对九个数据库进行电子检索并进行手工检索。两名作者将独立进行筛选(题目、摘要和全文阶段)、提取数据并评估偏倚风险。计划采用随机效应模型进行荟萃分析。如果无法进行荟萃分析,将采用叙述性综合方法总结评价的特征和结果。如果有超过10项研究,将评估发表偏倚。将根据数据可得性进行敏感性和亚组分析。我们将使用“评估系统评价的方法学质量”和“推荐分级、评估、制定与评价”来评估本评价的质量。
整个项目的方案已获得主办机构伦理委员会(印度马尼帕尔马尼帕尔大学机构伦理委员会)以及印度政府卫生和家庭福利部下属的“卫生部筛查委员会”的批准。研究结果将通过知识传播研讨会、政策简报、出版物等方式在相关利益攸关方中传播。
PROSPERO注册号:CRD42016044019。